These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 9219913)

  • 1. Limited proteolysis of high density lipoprotein abolishes its interaction with cell-surface binding sites that promote cholesterol efflux.
    Mendez AJ; Oram JF
    Biochim Biophys Acta; 1997 Jun; 1346(3):285-99. PubMed ID: 9219913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative tyrosylation of HDL enhances the depletion of cellular cholesteryl esters by a mechanism independent of passive sterol desorption.
    Francis GA; Oram JF; Heinecke JW; Bierman EL
    Biochemistry; 1996 Dec; 35(48):15188-97. PubMed ID: 8952466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol.
    Mendez AJ; Anantharamaiah GM; Segrest JP; Oram JF
    J Clin Invest; 1994 Oct; 94(4):1698-705. PubMed ID: 7929849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High density lipoprotein apolipoproteins mediate removal of sterol from intracellular pools but not from plasma membranes of cholesterol-loaded fibroblasts.
    Oram JF; Mendez AJ; Slotte JP; Johnson TF
    Arterioscler Thromb; 1991; 11(2):403-14. PubMed ID: 1998658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of free apolipoprotein-mediated cellular lipid efflux by probucol.
    Tsujita M; Yokoyama S
    Biochemistry; 1996 Oct; 35(40):13011-20. PubMed ID: 8855936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of apolipoproteins AI, AII, and Cs on the metabolism of membrane and lysosomal cholesterol in macrophages.
    Mahlberg FH; Glick JM; Lund-Katz S; Rothblat GH
    J Biol Chem; 1991 Oct; 266(30):19930-7. PubMed ID: 1657906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of high-density lipoprotein particles containing apo A-I, with or without apo A-II, on intracellular cholesterol efflux.
    Oikawa S; Mendez AJ; Oram JF; Bierman EL; Cheung MC
    Biochim Biophys Acta; 1993 Jan; 1165(3):327-34. PubMed ID: 8418891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phospholipid transfer protein enhances removal of cellular cholesterol and phospholipids by high-density lipoprotein apolipoproteins.
    Wolfbauer G; Albers JJ; Oram JF
    Biochim Biophys Acta; 1999 Jul; 1439(1):65-76. PubMed ID: 10395966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease.
    Francis GA; Knopp RH; Oram JF
    J Clin Invest; 1995 Jul; 96(1):78-87. PubMed ID: 7615839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance of smooth muscle cells to assembly of high density lipoproteins with extracellular free apolipoproteins and to reduction of intracellularly accumulated cholesterol.
    Komaba A; Li Q; Hara H; Yokoyama S
    J Biol Chem; 1992 Sep; 267(25):17560-6. PubMed ID: 1517206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lecithin:cholesterol acyltransferase reaction on cellular lipid released by free apolipoprotein-mediated efflux.
    Czarnecka H; Yokoyama S
    Biochemistry; 1995 Apr; 34(13):4385-92. PubMed ID: 7703252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol mobilization by free and lipid-bound apoAI(Milano) and apoAI(Milano)-apoAII heterodimers.
    Wang WQ; Moses AS; Francis GA
    Biochemistry; 2001 Mar; 40(12):3666-73. PubMed ID: 11297434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular cholesterol transport and efflux in fibroblasts are abnormal in subjects with familial HDL deficiency.
    Marcil M; Yu L; Krimbou L; Boucher B; Oram JF; Cohn JS; Genest J
    Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):159-69. PubMed ID: 9888879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol efflux mediated by apolipoproteins is an active cellular process distinct from efflux mediated by passive diffusion.
    Mendez AJ
    J Lipid Res; 1997 Sep; 38(9):1807-21. PubMed ID: 9323590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol efflux from macrophages mediated by high-density lipoprotein subfractions, which differ principally in apolipoprotein A-I and apolipoprotein A-II ratios.
    von Hodenberg E; Heinen S; Howell KE; Luley C; Kübler W; Bond HM
    Biochim Biophys Acta; 1991 Nov; 1086(2):173-84. PubMed ID: 1932099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Displacement of apo A-I from HDL by apo A-II or its C-terminal helix promotes the formation of pre-beta1 migrating particles and decreases LCAT activation.
    Labeur C; Lambert G; Van Cauteren T; Duverger N; Vanloo B; Chambaz J; Vandekerckhove J; Castro G; Rosseneu M
    Atherosclerosis; 1998 Aug; 139(2):351-62. PubMed ID: 9712342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABCG1 redistributes cell cholesterol to domains removable by high density lipoprotein but not by lipid-depleted apolipoproteins.
    Vaughan AM; Oram JF
    J Biol Chem; 2005 Aug; 280(34):30150-7. PubMed ID: 15994327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efflux of lysosomal cholesterol from cells.
    Johnson WJ; Chacko GK; Phillips MC; Rothblat GH
    J Biol Chem; 1990 Apr; 265(10):5546-53. PubMed ID: 2318824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective down-regulation by protein kinase C inhibitors of apolipoprotein-mediated cellular cholesterol efflux in macrophages.
    Li Q; Tsujita M; Yokoyama S
    Biochemistry; 1997 Oct; 36(40):12045-52. PubMed ID: 9315842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol efflux from macrophages and other cells.
    von Eckardstein A
    Curr Opin Lipidol; 1996 Oct; 7(5):308-19. PubMed ID: 8937522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.